[177Lu]Lu-BQ7876

N/A

Report date: 2025/09/19 16:19:12

Base Information

Drug Name[177Lu]Lu-BQ7876

Drug Alias Name[177Lu]Lu-BQ7876Lutetium-177 Labeled BQ7876

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionSingle-photon emission-computed tomography enhancersProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesTomsk National Research Medical Center Of The Russian Academy Of Sciences

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A